This review highlights that non-vitamin K oral anticoagulants are a promising alternative to vitamin K antagonists for treating left atrial appendage thrombi in patients with atrial fibrillation.
Answers are grounded in this paper and cite their sources.
May support NOAC use for LAA thrombus in AF; leaves open need for randomized trials versus VKAs.
Thrombi in the left atrial appendage (LAA) are an important cause of systemic thromboembolism in patients with atrial fibrillation. The gold standard for the diagnosis of LAA thrombi is a transesophageal echocardiogram, although cardiac multidetector computed tomography, intracardiac echocardiogram, and cardiac magnetic resonance imaging are alternative diagnostic imaging modalities. When an LAA thrombus is diagnosed, effective anticoagulation is recommended for at least 3 weeks or until thrombus resolution is confirmed on repeat transesophageal echocardiogram. Recent prospective research shows the efficacy of nonvitamin K oral anticoagulants in the treatment of LAA thrombus, which offers a promising alternative to vitamin K antagonists. As an alternative approach, left atrial aspiration thrombectomy has been described in case reports, though there is limited evidence comparing its efficacy to anticoagulation alone.
No takes yet. Share an insight, caveat, or question.
Feldman et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: